ArticleLiver cancer2023

Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.

Yuwa Ando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.